Long COVID Drug
![Long COVID Drug, AIM Immunotech, Shareholders](https://pharmtales.com/wp-content/uploads/2023/08/Activist-Investors-Renew-Battle-Against-Biotech-Pioneering-Long-COVID-Treatment-at-AIM-Immunotech.jpg)
Activist Investors Renew Battle Against Biotech Pioneering Long COVID Treatment at AIM Immunotech
Anika Sharma
In the ever-shifting landscape of corporate battles, AIM Immunotech finds itself once again on the front lines, grappling with a ...